SOX9 knockout decreases stemness properties in colorectal cancer cells.

Background: Colorectal cancer (CRC) is a leading cause of death worldwide. SRY-box transcription factor 9 (SOX9) participates in organogenesis and cell differentiation in normal tissues but has been involved in carcinogenesis development. Cancer stem cells (CSCs) are a small population of cells present in solid tumors that contribute to increased tumor heterogeneity, metastasis, chemoresistance, and relapse. CSCs have properties such as self-renewal and differentiation, which can be modulated by many factors. Currently, the role of SOX9 in the maintenance of the stem phenotype has not been well elucidated, thus, in this work we evaluated the effect of the absence of SOX9 in the stem phenotype of CRC cells.

Methods: We knockout (KO) in the undifferentiated CRC cell line HCT116 and evaluated their stemness properties using sphere formation assay, differentiation assay, and immunophenotyping.

Results: affected the epithelial morphology of HCT116 cells and stemness characteristics such as its pluripotency signature with the increase of as a compensatory mechanism to induce SOX9 expression, the increase of as a differentiation feature, as well as the inhibition of the stem cell markers CD44 and CD73. In addition, cells gain the epithelial-mesenchymal transition (EMT) phenotype with a significant upregulation of . Furthermore, our results showed a remarkable effect on first- and second-sphere formation, being cells less capable of forming high-size-resistant spheres. Nevertheless, CSCs surface markers were not affected during the differentiation assay.

Conclusions: Collectively, our findings supply evidence that SOX9 promotes the maintenance of stemness properties in CRC-CSCs.